GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elos Medtech AB (CHIX:ELOSBs) » Definitions » Change In Receivables

Elos Medtech AB (CHIX:ELOSBS) Change In Receivables : kr0.0 Mil (TTM As of Sep. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Elos Medtech AB Change In Receivables?

Elos Medtech AB's change in receivables for the quarter that ended in Sep. 2023 was kr0.0 Mil. It means Elos Medtech AB's Accounts Receivable stayed the same from Jun. 2023 to Sep. 2023 .

Elos Medtech AB's change in receivables for the fiscal year that ended in Dec. 2021 was kr-20.2 Mil. It means Elos Medtech AB's Accounts Receivable increased by kr20.2 Mil from Dec. 2020 to Dec. 2021 .

Elos Medtech AB's Accounts Receivable for the quarter that ended in Sep. 2023 was kr0.0 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Elos Medtech AB's Days Sales Outstanding for the three months ended in Sep. 2023 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Elos Medtech AB's liquidation value for the three months ended in Sep. 2023 was kr-654.7 Mil.


Elos Medtech AB Change In Receivables Historical Data

The historical data trend for Elos Medtech AB's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elos Medtech AB Change In Receivables Chart

Elos Medtech AB Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -19.35 2.78 12.99 -15.33 -20.24

Elos Medtech AB Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Elos Medtech AB Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elos Medtech AB  (CHIX:ELOSBs) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Elos Medtech AB's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/251.2*91
=0.00

2. In Ben Graham's calculation of liquidation value, Elos Medtech AB's accounts receivable are only considered to be worth 75% of book value:

Elos Medtech AB's liquidation value for the quarter that ended in Sep. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=117.3-772+0.75 * 0+0.5 * 0
=-654.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elos Medtech AB Change In Receivables Related Terms

Thank you for viewing the detailed overview of Elos Medtech AB's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Elos Medtech AB (CHIX:ELOSBS) Business Description

Traded in Other Exchanges
N/A
Address
Torsgatan 5B, Gothenburg, SWE, 411 04
Elos Medtech AB operates in the medical technology business. It develops and produces medical technology products and components. The company operates through three business segments including Dental, Orthopedics, and Life science. Some of its products include Implants, Screws, Plates, Prosthetics, and Drills.

Elos Medtech AB (CHIX:ELOSBS) Headlines

No Headlines